The latest C.R. Bard mesh lawsuit update relates to the C.R. Bard multidistrict litigation (MDL) being heard in a federal court in West Virginia. According to a court document filed in late June 2014, the parties were in a disagreement over the deposition of C.R. Bard CEO John Weiland.
According to the court document, the defendants argued that the plaintiffs could gather pertinent information on C.R. Bard transvaginal mesh products without deposing Weiland. In making this argument, the defendants deemed the plaintiffs deposition request as unnecessarily disruptive to C.R. Bard business.
U.S. Magistrate Judge Cheryl A. Eifert ordered that plaintiffs shall be allowed to depose Weiland, but with limitations. Though the order disallows plaintiffs to question Weiland about technical aspects of C.R. Bard transvaginal mesh products, the plaintiffs have been permitted to ask Weiland about his involvement, as a C.R. Bard executive, in monitoring and addressing product quality and safety.
The defective medical device lawyers at Carey Danis & Lowe find that Judge Eifert’s ruling is a wise one.
Carey Danis & Lowe is a national law firm that represents transvaginal mesh victims. We have a team of experienced trial lawyers that have been successful in recovering over $1 billion on behalf of our clients. Explore your legal options with Carey Danis & Lowe today in a free initial case evaluation.
Contact Carey Danis & Lowe by phone at 800.721.2519, or by submitting a confidential personal injury claim form.References: Defective Medical Device litigation, Transvaginal Mesh